These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34289424)

  • 1. Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis.
    Cai L; Zhang C; Wu J; Zhou W; Chen T
    Clin Immunol; 2021 Aug; 229():108800. PubMed ID: 34289424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased PD-1 expression on circulating CD4
    Cai L; Zhang C; Wu J; Zhou W; Chen T
    Joint Bone Spine; 2019 Jan; 86(1):61-68. PubMed ID: 29609005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentages of PD-1
    Wang Y; Pang N; Wang X; Liu Y; Wang X; Wang L; Sun M; Yasen H; Zhao F; Fan W; Guo X; Ding J
    Hum Vaccin Immunother; 2018 Apr; 14(4):832-838. PubMed ID: 29333980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
    Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
    [No Abstract]   [Full Text] [Related]  

  • 5. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus].
    Luo L; Shu M; Li S; Cai Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
    Mortensen JB; Monrad I; Enemark MB; Ludvigsen M; Kamper P; Bjerre M; d'Amore F
    Eur J Haematol; 2021 Jul; 107(1):81-91. PubMed ID: 33721375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients.
    Wu D; Liu Y; Pang N; Sun M; Wang X; Haridia Y; Zhao F; Qin Y; Fan W; Guo X; Ding J
    Medicine (Baltimore); 2019 Oct; 98(43):e17608. PubMed ID: 31651870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble PD-L1 with PD-1-binding capacity exists in the plasma of patients with non-small cell lung cancer.
    Takeuchi M; Doi T; Obayashi K; Hirai A; Yoneda K; Tanaka F; Iwai Y
    Immunol Lett; 2018 Apr; 196():155-160. PubMed ID: 29366663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of total glucosides of paeony on PD-1/PD-L1 expression in primary Sjögren's syndrome.
    Chen Y; Wang Y; Xu L; Zhu W; Xu C; Xu M; Guo L; Hu W; Xu D; Jing R; Zhu Y; He J; Xu B
    Int J Rheum Dis; 2019 Feb; 22(2):200-206. PubMed ID: 30338648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.
    Chang B; Huang T; Wei H; Shen L; Zhu D; He W; Chen Q; Zhang H; Li Y; Huang R; Li W; Wu P
    Cancer Immunol Immunother; 2019 Mar; 68(3):353-363. PubMed ID: 30506460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity.
    Hirahara S; Katsumata Y; Kawasumi H; Kawaguchi Y; Harigai M
    Lupus; 2020 Jun; 29(7):686-696. PubMed ID: 32264742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer.
    Zhang J; Zhang H; Luo Y
    Med Sci Monit; 2019 Feb; 25():1275-1282. PubMed ID: 30771277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
    Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
    Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the Expression Levels and Clinical Significance of PD-1 and PD-L1 in Plasma of NSCLC Patients.
    He J; Pan Y; Guo Y; Li B; Tang Y
    J Immunother; 2020 Jun; 43(5):156-164. PubMed ID: 32168233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction.
    Okuyama M; Mezawa H; Kawai T; Urashima M
    Front Immunol; 2019; 10():86. PubMed ID: 30833943
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity.
    Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J
    Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PD-1/PD-Ls in the pathogenesis of IgG4-related disease.
    Zhang X; Lu H; Peng L; Zhou J; Wang M; Li J; Liu Z; Zhang W; Zhao Y; Zeng X; Lu L
    Rheumatology (Oxford); 2022 Feb; 61(2):815-825. PubMed ID: 33930105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer].
    Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
    Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.
    Cho I; Lee H; Yoon SE; Ryu KJ; Ko YH; Kim WS; Kim SJ
    BMC Cancer; 2020 Feb; 20(1):120. PubMed ID: 32054467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.